# A Study to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine

> **NCT03718468** · PHASE3 · COMPLETED · sponsor: **Medigen Vaccine Biologics Corp.** · enrollment: 842 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** GC FLU Quadrivalent
- **BIOLOGICAL:** Fluarix Tetra

## Key facts

- **NCT ID:** NCT03718468
- **Lead sponsor:** Medigen Vaccine Biologics Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-30
- **Primary completion:** 2019-07-03
- **Final completion:** 2019-07-03
- **Target enrollment:** 842 (ACTUAL)
- **Last updated:** 2019-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03718468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03718468, "A Study to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03718468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*